Skift Take
The hunt is on for a silver bullet that rubber stamps an employee's immunity to Covid-19. Only then will corporations be able to kickstart their business travel.
Passenger authentication in the corporate travel sector could be ripe for disruption, and there are already signs of companies moving in.
Software company Bizagi last week launched the CoronaPass, a certification system app that allows employees to demonstrate their immunity to authorities when required, based on the results of Covid-19 antibody testing.
Consultancy giant Ernst & Young is among the first to sign up to it, to help its own employees and other businesses return to work.
Ernst & Young has a substantial travel team with a global spend of $2.2 billion on travel, meetings and events. Once trialled internally, it's likely it will roll out the platform to its corporate clients looking to get staff back out on the road.
Bizagi CEO Gustavo Gomez told Skift this is an example of the app being used in the private sector, but it also wants to collaborate with health authorities around the world to help pave the way for international travel to resume as seamlessly as possible. The platform even has a “travel request process” built in.
TESTING TIMES
As pharmaceutical companies work on developing a vaccine, Gomez said the app would use a points-based system based on test results.
Swiss pharmaceutical company Roche is due to develop a reliable immunity test for early May, while other independent tests are available. Gomez said CoronaPass can factor in results from more than one test, and if someone passes all of them, it increases that person’s score.
The World Health Organization also ranks countries on the quality of their health sy
